In the wake of lightning fast authorisations of covid-19 vaccines in the UK and the US, public health officials have worked hard to maintain confidence in these new products.
NEJM
The New England Journal of Medicine is a research journal for Peer-reviewed and research papers.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant | NEJM
These findings corresponded to a vaccine efficacy of 49.4% (95% confidence interval [CI], 6.1 to 72.8), which met the criterion for efficacy in the primary phase 2b evaluation (Table 2 and Figure 2A).
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden
In mid-March 2020, many countries decided to close schools in an attempt to limit the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (Covid-19).1,2 Sweden was one of the few countries that decided to keep preschools (generally caring for children 1 to 6 years of age) and schools (with children 7 to 16 years of age) open.
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial.